Evaluation of Remote Programming of Cochlear Implants in Routine Cochlear Implant Follow-up
NCT ID: NCT06894303
Last Updated: 2025-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
51 participants
OBSERVATIONAL
2025-02-03
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Anatomy-Based Cochlear Implant Programming on Early Performance
NCT06734039
Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation
NCT04048239
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
NCT05810220
Clinical Evaluation of a Cochlear Implant Sound Processor
NCT04237207
An Actual Use, Open-label Study Assessing Usability of Remote Assist to Program Cochlear Implant Recipients
NCT04987021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Unilateral users
Target CI v1.5 remote programming
Use of the remote programming function of Target CI v1.5 and the AB remote support application
Group 2
Bilateral users
Target CI v1.5 remote programming
Use of the remote programming function of Target CI v1.5 and the AB remote support application
Group 3
Bimodal users
Target CI v1.5 remote programming
Use of the remote programming function of Target CI v1.5 and the AB remote support application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Target CI v1.5 remote programming
Use of the remote programming function of Target CI v1.5 and the AB remote support application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to give feedback on hearing impressions
* Aged 18 years of age or older
* Implanted with a HiResolution Bionic Ear System (HiRes 90K or HiRes 90K Advantage or HiRes Ultra or HiRes Ultra 3D) on at least one side
* Group 1 - Unilateral: no hearing device except contralateral routing of signals (CROS) device on the contralateral side
* Group 2 - Bilateral: implanted on both sides
* Group 3 - Bimodal: hearing aid on the contralateral side
* Minimum of six months of cochlear implant experience
* Minimum of one month experience with a Naída CI M or Sky CI M sound processor
* Fluent in French language
* Ability to be tested via speech perception test in noise
* Smartphone user
Exclusion Criteria
* Unrealistic expectations regarding potential benefits, risks and limitations of the investigational device as determined by the Investigator
* Unwillingness or inability of subject to comply with all investigational requirements as determined by the Investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Advanced Bionics AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupement Hospitalier Pitié Salpêtrière
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABInt-24-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.